125 related articles for article (PubMed ID: 11295084)
1. Oncoprotein changes in the flat lesions with atypia and invasive neoplasms of the urinary bladder.
Kee KH; Lee MJ; Ro JY
Oncol Rep; 2001; 8(3):579-83. PubMed ID: 11295084
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of epidermal growth factor receptor, transforming growth factor alpha, epidermal growth factor and c-erbB2 in the progression of invasive bladder cancer.
Ravery V; Grignon D; Angulo J; Pontes E; Montie J; Crissman J; Chopin D
Urol Res; 1997; 25(1):9-17. PubMed ID: 9079740
[TBL] [Abstract][Full Text] [Related]
3. Expression and functions of EGF, FGF and TGFbeta-growth-factor family members and their receptors in invasive human transitional-cell-carcinoma cells.
De Boer WI; Houtsmuller AB; Izadifar V; Muscatelli-Groux B; Van der Kwast TH; Chopin DK
Int J Cancer; 1997 Apr; 71(2):284-91. PubMed ID: 9139855
[TBL] [Abstract][Full Text] [Related]
4. Flat intraepithelial lesions of the urinary bladder.
Cheng L; Cheville JC; Neumann RM; Bostwick DG
Cancer; 2000 Feb; 88(3):625-31. PubMed ID: 10649257
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of progression-related genes in the evolution of superficial to invasive transitional cell carcinoma of the bladder.
Izawa JI; Slaton JW; Kedar D; Karashima T; Perrotte P; Czerniak B; Grossman HB; Dinney CP
Oncol Rep; 2001; 8(1):9-15. PubMed ID: 11115562
[TBL] [Abstract][Full Text] [Related]
6. E-cadherin expression in urothelial carcinoma in situ, superficial papillary transitional cell carcinoma, and invasive transitional cell carcinoma.
Sun W; Herrera GA
Hum Pathol; 2002 Oct; 33(10):996-1000. PubMed ID: 12395372
[TBL] [Abstract][Full Text] [Related]
7. Highly invasive transitional cell carcinoma of the bladder in a simian virus 40 T-antigen transgenic mouse model.
Grippo PJ; Sandgren EP
Am J Pathol; 2000 Sep; 157(3):805-13. PubMed ID: 10980120
[TBL] [Abstract][Full Text] [Related]
8. Expression of cell cycle-associated proteins in non-muscle-invasive bladder cancer: correlation with intravesical recurrence following transurethral resection.
Behnsawy HM; Miyake H; Abdalla MA; Sayed MA; Ahmed Ael-F; Fujisawa M
Urol Oncol; 2011; 29(5):495-501. PubMed ID: 19914103
[TBL] [Abstract][Full Text] [Related]
9. [Urothelial hyperplastic lesion with endophytic growth pattern: a clinicopathologic study].
Xiao L; Wang CF; Zhu XZ; Yin YL; Chen Y; Lu C; Yu B
Zhonghua Bing Li Xue Za Zhi; 2011 May; 40(5):319-23. PubMed ID: 21756826
[TBL] [Abstract][Full Text] [Related]
10. Targeted Next-Generation Sequencing of Flat Urothelial Lesions Reveals Putative Pathobiological Pathways, Potential Biomarkers, and Rational Therapeutic Targets.
Musangile FY; Matsuzaki I; Iwamoto R; Sagan K; Nishikawa M; Mikasa Y; Takahashi Y; Kojima F; Hara I; Murata SI
Mod Pathol; 2023 May; 36(5):100120. PubMed ID: 36812689
[TBL] [Abstract][Full Text] [Related]
11. DNA copy number alterations and PPARG amplification in a patient with multifocal bladder urothelial carcinoma.
Conconi D; Panzeri E; Redaelli S; Bovo G; Volante M; Viganò P; Strada G; Dalprà L; Bentivegna A
BMC Res Notes; 2012 Oct; 5():607. PubMed ID: 23114535
[TBL] [Abstract][Full Text] [Related]
12. Predictive value of expression of transforming growth factor-beta(1) and its receptors in transitional cell carcinoma of the urinary bladder.
Kim JH; Shariat SF; Kim IY; Menesses-Diaz A; Tokunaga H; Wheeler TM; Lerner SP
Cancer; 2001 Sep; 92(6):1475-83. PubMed ID: 11745225
[TBL] [Abstract][Full Text] [Related]
13. Growth factors and oncogene products in transitional cell carcinoma.
Nakanishi K; Kawai T; Suzuki M; Torikata C
Mod Pathol; 1996 Mar; 9(3):292-7. PubMed ID: 8685230
[TBL] [Abstract][Full Text] [Related]
14. CK20 and p53 Immunohistochemical Staining Patterns in Urinary Bladder Specimens With Equivocal Atypia.
Arias-Stella JA; Shah AB; Gupta NS; Williamson SR
Arch Pathol Lab Med; 2018 Jan; 142(1):64-69. PubMed ID: 28967804
[TBL] [Abstract][Full Text] [Related]
15. [Transitional cell carcinoma of the prostate in cystoprostatectomy specimens].
Liedberg F; Chebil G; Davidsson T; Malmström PU; Sherif A; Månsson W
Aktuelle Urol; 2003 Sep; 34(5):333-6. PubMed ID: 14566661
[TBL] [Abstract][Full Text] [Related]
16. Clinical implications of the expression of epidermal growth factor receptors in human transitional cell carcinoma.
Messing EM
Cancer Res; 1990 Apr; 50(8):2530-7. PubMed ID: 1690599
[TBL] [Abstract][Full Text] [Related]
17. Analysis of 90 step-sectioned cystectomized specimens of bladder cancer.
Kakizoe T; Matsumoto K; Nishio Y; Kishi K
J Urol; 1984 Mar; 131(3):467-72. PubMed ID: 6699986
[TBL] [Abstract][Full Text] [Related]
18. Noninvasive squamous lesions in the urinary bladder: a clinicopathologic analysis of 29 cases.
Guo CC; Fine SW; Epstein JI
Am J Surg Pathol; 2006 Jul; 30(7):883-91. PubMed ID: 16819332
[TBL] [Abstract][Full Text] [Related]
19. The immunohistochemical detection of cripto-1 in benign and malignant human bladder.
Byrne RL; Autzen P; Birch P; Robinson MC; Gullick WJ; Neal DE; Hamdy FC
J Pathol; 1998 May; 185(1):108-11. PubMed ID: 9713367
[TBL] [Abstract][Full Text] [Related]
20. c-myc in bladder cancer. Clinical findings and analysis of mechanism.
Schmitz-Dräger BJ; Schulz WA; Jürgens B; Gerharz CD; van Roeyen CR; Bültel H; Ebert T; Ackermann R
Urol Res; 1997; 25 Suppl 1():S45-9. PubMed ID: 9079756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]